New report showcases resourceful leaders in UK bioscience for challenging times


10-11-2020
BioBeat '20 logo

Released today by BioBeat, the seventh annual Movers and Shakers in BioBusiness report highlights 30 examples of resourceful leaders in the UK bioscience sector.

The UK life sciences sector has risen to the challenges posed by COVID-19 with exceptional innovation and collaboration across industry, clinicians, the NHS, academia and government. Members of the BioBeat community are at the forefront of global scientific research and clinical trials, significantly shaping the trajectory of the pandemic.

Many of the leaders featured in the report have been instrumental in the response to the COVID-19 pandemic, while others are pioneering healthcare innovations that will bring benefits to patients across a wide range of conditions.

Taking the theme ‘Connecting for Strength’, the report showcases women at the forefront of the UK’s flourishing life sciences sector including:

  • Pioneering scientists developing revolutionary healthcare products
  • Financial experts shaping the sector through diverse investments
  • Motivating and inclusive collaborators who get the job done
  • Innovators whose inventions are making an impact on patients’ lives
  • Infrastructure specialists supporting innovation at scale, from concept to execution

For the first time, this year’s Movers and Shakers also features nearly 200 alumni from previous reports, demonstrating the strength and breadth of the BioBeat community across UK life sciences.

Introducing the report, Kate Bingham, Chair of the UK Vaccine Task Force, trustee of the Francis Crick Institute and Managing Partner at SV Health Investors, says: “The women profiled within this report are outstanding leaders who are changing the face and future of healthcare. Each has contributed immensely to the UK’s world-class science, retaining talent, driving economic growth and improving patient care through the COVID-19 pandemic and beyond. Their successes will inspire our next generation of scientists and encourage the growth of a more diverse talent pool.”

BioBeat founder Miranda Weston-Smith adds: “It is the strength in our human connections that enables entrepreneurs and researchers to bring ideas to life. The COVID-19 pandemic has brought out the very best of British science, highlighting the resilience of the sector and our capacity for collaboration and innovation. Congratulations to all the leaders profiled in this year’s report, and heartfelt thanks to the nominators and expert reviewers who provide their time and insights to make this such a valuable resource.”

The Movers and Shakers in BioBusiness report is released in advance of the BioBeat20 Summit: Accelerating data-driven health on Tuesday 17th November 2020, in partnership with the Francis Crick Institute.

Delivered as an online event this year, the summit will bring together leading experts to discuss the tipping points for data-driven health adoption and investment.

It’s an unmissable opportunity to explore what’s driving clinical and patient adoption of digital health technologies, examine the critical influences on investment and weigh-up how global trends are shaping companies.

The full Movers & Shakers in BioBusiness 2020 report is available to download here

Free registration is now open for the BioBeat20 summit: Accelerating data-driven health at crick.ac.uk/whats-on/biobeat20

 

About BioBeat

BioBeat connects entrepreneurs with leaders in bioscience, by working to respond to challenges and open opportunities through the inspirational experience of women leaders. Miranda Weston-Smith founded BioBeat to bring fresh energy and insights for a healthier world.

BioBeat has produced the Movers & Shakers in BioBusiness report every year since 2014, identifying outstanding female leadership talent in UK bioscience. The annual BioBeat summit brings together pioneers in biotech to nurture innovation and forge new partnerships.

Find out more at mws-consulting.co.uk/biobeat/ 

About BioBeat’s Movers and Shakers in BioBusiness report

The women highlighted in this year’s report have been nominated by the biobusiness community, together with Miranda’s research and insights. The selection was reviewed by a distinguished panel of business leaders, entrepreneurs and pioneering scientists working in the UK life sciences sector

About the BioBeat20 Summit

Time: 14:00-16:45, Tuesday 17th November 2020

Location: The Francis Crick Institute, London/Zoom videoconferencing

BioBeat20: Accelerating data-driven health is a half-day event for scientists, investors and entrepreneurs, discussing the tipping points for data-driven health adoption and investment. It’s an opportunity to explore what’s driving clinical and patient adoption of digital health technologies, examine the critical influences on investment and weigh-up how global trends are shaping companies.

The keynote lecture will be given by Samra Turajlic, Group Leader at the Francis Crick Institute and Consultant Medical Oncologist at the Royal Marsden Hospital, who will speak about the opportunities, challenges and practicalities of bringing data-driven healthcare to the clinic.

This year’s summit will be an online event. View the full programme and register to attend via Zoom for free at crick.ac.uk/whats-on/biobeat20

About our partners

The Movers and Shakers in BioBusiness report and BioBeat20 are produced with the support of:

  • Appleyard Lees
  • AstraZeneca
  • Covington & Burling LLP
  • Entrepreneurship Centre, University of Cambridge Judge Business School
  • The Francis Crick Institute
  • Innovation Forum
  • One Nucleus
 

Miranda helps early stage biomedical businesses to attract investment and develop their business strategy. Miranda founded and runs BioBeat, a programme to inspire the next wave of bioentrepreneurs and business leaders

Miranda Weston-Smith